The central event in prion infection is the conformational conversion of host-encoded cellular prion protein (PrP C ) into the pathogenic isoform (PrP Sc ). Diverse mammalian species possess the cofactors required for in vitro replication of PrP Sc by protein-misfolding cyclic amplification (PMCA), but lower organisms, such as bacteria, yeasts, and insects, reportedly lack the essential cofactors. Various cellular components, such as RNA, lipids, and other identified cofactor molecules, are commonly distributed in both eukaryotes and prokaryotes, but the reasons for the absence of cofactor activity in lower organisms remain to be elucidated. Previously, we reported that brain-derived factors were necessary for the in vitro replication of glycosylphosphatidylinositol-anchored baculovirus-derived recombinant PrP (Bac-PrP). Here, we demonstrate that following protease digestion and heat treatment, insect cell lysates had the functional cofactor activity required for BacPrP replication by PMCA. Mammalian PrP Sc seeds and Bac-PrP Sc generated by PMCA using Bac-PrP and insect cell-derived cofactors showed similar pathogenicity and produced very similar lesions in the brains of inoculated mice. These results suggested that the essential cofactors required for the high-fidelity replication of mammalian PrP Sc were present in the insect cells but that the cofactor activity was masked or inhibited in the native state. We suggest that not only RNA, but also DNA, are the key components of PMCA, although other cellular factors were necessary for the expression of the cofactor activity of nucleic acids. PMCA using only insect cell-derived substances (iPMCA) was highly useful for the ultrasensitive detection of PrP Sc of some prion strains.
Introduction
Transmissible spongiform encephalopathies (TSEs), including scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, and Creutzfeldt-Jakob disease in humans, are infectious and fatal neurodegenerative diseases [1] . Unique proteinaceous infectious agents called prions are considered to be the cause of TSEs. Prions consist primarily of a pathogenic form (PrP Sc ) of the normal cellular prion protein (PrP   C   ) and PrP Sc appears to propagate itself via autocatalytic conformational conversion of PrP C [2] . Although the conversion mechanism of PrP C into PrP Sc remains unclear, host cofactors have been suggested to be necessary for the efficient replication of PrP Sc in addition to the PrP C substrate [3] . Various biological molecules including nucleic acids, sulfate glycans, lipids, proteins [4, 5, 6, 7, 8, 9, 10] , and nicotinamide adenine dinucleotide phosphate (NADPH) [11] have been reported to act as cofactors for the conversion of PrP C into PrP Sc , suggesting that it is not possible to attribute cofactor activity to a specific molecule. Furthermore, the dependency on such cofactors varies among the animal or prion strains examined [12] . Therefore, a more detailed analysis of the cofactors is needed to identify the conversion mechanism of PrP C and to initiate the development of new potential therapies targeting cofactors.
Protein misfolding cyclic amplification (PMCA) is used to amplify minute amounts of PrP Sc to easily detectable levels and its usefulness for highly sensitive and specific detection of prions has been established [13, 14, 15, 16, 17] . Typically, brain homogenate from normal animals is used as the PrP C substrate for amplification and PrP Sc amplified by PMCA retains similar biochemical and biological characteristics to the prion strain used as the PrP Sc seed [18] . Therefore, PMCA using brain homogenates is expected to mimic the in vivo replication of PrP Sc and it is a useful experimental system to elucidate the complexity of prions, such as the existence of prion strains and the PrP Sc replication mechanism. Indeed, PMCA has been used in studies concerning species barriers in prion transmission [19, 20, 21] and to investigate the cofactors involved in the replication of PrP Sc [12, 22] . Abid et al. [22] suggested that the cofactors required for amplification of 263K PrP Sc are contained in various mammalian tissues such as the liver, kidney, heart, and muscles of mammals, whereas lower organisms such as bacteria, yeasts, and flies do not possess cofactor activities. Previously, we reported that baculovirus-derived recombinant PrP (Bac-PrP) modified with glycosylphosphatidylinositol (GPI) was converted by PMCA (Bac-PMCA) into a PrP Sc form (Bac-PrP Sc ) that retained the strain-specific characteristics of the PrP Sc seed used [23] . Bac-PrP Sc was not amplified with insect cell-derived substances alone and the addition of Prnp 0/0 mouse brain homogenate to the reaction mixture was necessary for amplification [23] . These observations suggested that mammal-derived cofactors were also essential for in vitro Bac-PrP Sc replication. However, the cofactors or cofactor candidates identified to date are universal cellular components common to both eukaryotes and prokaryotes [4, 5, 6, 7, 8, 9, 10] . More specifically, RNA derived from worms, as well as mammalian RNA, efficiently amplified hamster scrapie prions [24] . Furthermore, prion-like proteins, which are transmissible proteins accompanied by a structural conversion of protein, are well known in yeasts [25] . Therefore, it is probable that nonmammalian species also possess cofactors that can induce the posttranslational structural conversion of proteins. The apparent absence of cofactor activity in non-mammalian species may be due to its functional status; that is, cofactors of non-mammalian species may be in a non-functional state for the replication of mammalian prion proteins in cells.
Identifying the differences between mammalian and nonmammalian cofactors will contribute much towards our understanding of the mechanism of conformational changes of prion proteins. Reconstitution experiments using recombinant PrP and known materials are needed to achieve this purpose. Although Escherichia coli-derived GPI-anchorless recombinant PrP was available as a PrP C substrate in a PMCA reaction, the biological characteristics of the amplified PrP Sc were different from those of the PrP Sc seed [26] . On the other hand, GPI-anchored recombinant Bac-PrP Sc with the same strain-specific characteristics as the PrP Sc seed was generated by PMCA, with similar outcomes to conventional PMCA using brain homogenates. In the current study, we therefore reevaluated the cofactor activity for high-fidelity replication of PrP Sc using the Bac-PMCA system.
Materials and Methods

Ethics Statement
The animal experiments were approved by the Committee of Animal Experiment in National Institute of Animal Health (approval ID: 11-008, 13-005) and were performed in accordance with the Guideline for Animal Experiment at the Ministry of Agriculture, Forestry, and Fisheries of Japan.
Partial purification of Bac-PrP and brain-derived PrP C by immobilized metal ion affinity chromatography Insect cells expressing Bac-PrP (1610 8 cells) were lysed in 20 ml of TALON TM xTractor buffer (Clontech, Mountain View, CA) containing EDTA-free protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan) on ice with occasional agitation for 15 min. Following incubation, the cell lysate was centrifuged at 20,0006 g for 20 min at 4uC and the supernatant was cleared by filtering through a 0.45-mm filter. The clarified supernatant was loaded onto a His TALON TM super-flow cartridge (Clontech) equilibrated with 10 ml of equilibration buffer (16PBS, 300 mM NaCl, 1% Triton X-100) and the cartridge was washed with 10 ml of equilibration buffer and 20 ml of wash buffer (16 PBS, 300 mM NaCl, 2 mM imidazole, 1% Triton X-100). Bac-PrP was then eluted in 5 ml of elution buffer containing complete protease inhibitor cocktail (EDTA-free) (Roche Diagnostics, Mannheim, Germany).
Partial purification of PrP C from Tga20 transgenic mice brains was conducted as follows. Ten ml of 10% brain homogenate in 16 PBS, 1% SDC, 1% Triton X-100 and protease inhibitor cocktail (Nacalai Tesque) was incubated on ice with occasional agitation. After 2 min of sonication, the homogenate was centrifuged at 10,0006 g for 10 min at 4uC. After filtering through a 0.45-mm filter, the supernatant was loaded onto a His TALON TM super flow cartridge (Clontech). The cartridge was equilibrated, washed and eluted as described above.
Proteinase K and heat treatment of cell lysate
Five hundred microliters of HighFive TM cell suspension (5610 4 /ml in DW; Invitrogen, Carlsbad, CA), SF21 cell suspension (5610 4 /ml in DW; Invitrogen), N2a cell suspension (1.25 mg/ ml in DW) and Escherichia coli DH5a suspension (1.25 mg/ml in DW) were mixed with 500 ml of 26PMCA buffer (26PBS, 8 mM EDTA, 2% Triton X-100) respectively. Proteinase K (PK) was added to the mixtures to a final concentration of 100 mg/ml. Following sonication for 1 min, the cell lysate was incubated at 37uC for 1 h. After incubation, the cell lysate was heated at 100uC for 2.5 h to inactivate PK. The resultant cell lysates were designated as PKHF, PKSF21, PKN2a and PK E. coli, respectively.
Preparation of brain homogenate and PK treatment
To avoid contamination, the Prnp 0/0 mouse brain homogenate (Prnp 0/0 BH) was prepared in a laboratory in which infected materials had never been handled. Brains of Prnp 0/0 mice were homogenized at a 20% (w/v) concentration in 16 PBS containing a complete protease inhibitor cocktail (Roche). The BH was stored at 280uC until further use. The BH was mixed with an equal volume of 26PMCA buffer, and the 10% (w/v) BH was subjected to PMCA. The mouse-adapted scrapie strains, Chandler, 79A, 22L, ME7, Obihiro [27] , Tsukuba-2 (unpublished data) and mouse-adapted typical BSE (mBSE) were used as PrP Sc seeds. These prion strains were propagated in ICR mice. The brains of mice at the terminal stage of the disease were homogenized at 10% concentration (w/v) in 16 PBS.
PMCA
PMCA was carried out using the automatic cross-ultrasonic protein activating apparatus (ELESTEIN 070-GOT, Elekon Science Corp., Chiba, Japan), as reported previously (27) . Amplification was performed with 40 cycles of sonication (pulse oscillation for 3 s repeated five times at intervals of 0.1 s), followed by incubation at 37uC for 30 min with gentle agitation. For PMCA using PK-and heat-treated cell lysates, the reaction mixture was prepared by adding 5 ml of IMAC-purified Bac-PrP (approximately 101 ng/ml) or 6 ml of IMAC-purified brain-derived PrP C (approximately 125 ng/ml) to 10 ml of cell lysate and 85 ml of 16 PBS with 4 mM EDTA. For PMCA using whole insect cells expressing Bac-PrP, the PrP C substrate was prepared by adding 5 ml of Bac-PrP virus-infected cell suspension (5610 4 cells/ml, approximately 110 ng/ml) to 95 ml of 10% Prnp 0/0 BH. For conventional PMCA using normal BH as the PrP C substrate (BH-PMCA), 100 ml of 10% normal ICR mouse BH was used. The amplified products obtained after the first round of amplification
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Western blotting
The PMCA products were digested with 50 mg/ml PK at 37uC for 1 h. An equal volume of 26 SDS sample buffer was added to the samples and boiled for 5 min. The samples were separated by SDS-PAGE in NuPAGE 12% Bis-Tris gels (Invitrogen), and transferred onto PVDF membranes. The membranes were probed with anti-PrP horseradish peroxidase conjugate monoclonal antibody T2 [28] . The blotted membrane was developed with SuperSignal West Dura Extended Duration Substrate (Pierce, Rockford, IL), and chemiluminescence signals were detected using Chemiimager (Alpha InnoTec, San Leandro, CA).
Nuclease treatment of PKHF
Ribonuclease A (NipponGene) was added to PKHF at a final concentration of 500 mg/ml. DNase I (Takara) and benzonase (Novagen) were also added with 2 mM MgCl 2 at final concentrations of 500 and 1000 units/ml, respectively. Following the addition of nuclease, the PKHFs were incubated at 37uC overnight with shaking (850 rpm) and then heat-treated at 100uC for 10 min to inactivate the nucleases.
PCR
To obtain double stranded DNA fragments of different lengths, PCR was performed using Blend Taq polymerase (Toyobo, Tokyo, Japan). The thermocycling profile used for all products was 2 min at 94uC, followed by 40 cycles of 20 s at 94uC, 20 s at 55uC and 1 min at 72uC, followed by a final extension for 2 min at 72uC. The PCR products were purified using a QIAquick PCR purification kit (Qiagen, Valencia, CA, USA). The primers and templates used for the amplification of each product are as follows: for the 100-bp fragment derived from mouse GAPDH gene (M32599. 
Extraction of total lipids from brain
Brain total lipid was extracted from 0.1 g (equivalent to a brain) of freeze-dried Prnp 0/0 mouse brain powder twice using 6 ml of chloroform/methanol (2:1, v/v) and 7.2 ml of chloroform/ methanol (1:2:0.8, v/v/v). The extract was suspended in 200 ml of water, and 5 ml of the suspension were added to 100 ml of 16 PBS, 0.2% Triton X100, 4 mM EDTA and the PMCA reaction was performed.
Bioassay
The PMCA products subjected to bioassay were prepared as follows. Chandler-infected BH was diluted 1:1,000 with PrP C substrate, and then one round of PMCA was performed. Next, the process of 10-fold dilution of the PMCA product and its subsequent amplification was repeated three times. After that, the process of five-fold dilution of the PMCA product and its subsequent amplification was repeated six times. For mBSEseeded PMCA products, infected BH was diluted 1:1,000, and then one round of PMCA was performed. Next, the process of 10-fold dilution of the PMCA product and its subsequent amplification was repeated 12 times. For the negative control, normal BH was diluted 1:1,000, and then 13 rounds of sequential amplification was performed in a manner similar to that of mBSE amplification. The PMCA products were diluted 1:10 with 16 PBS, and 20 ml of each diluted sample was injected intracerebrally into 3-week-old C57BL/6J mice under sevoflurane anesthesia. The mice were housed in a biosafety level 3 room of our animal facility and their clinical status was monitored at least three times per week. Animals (total 21 mice) were euthanized by sevoflurane overdose following evidence of progressive neurologic dysfunction or more than 421 days post inoculation for control, and the brains were removed. The right hemisphere of the brain was fixed in formalin for histopathology analysis and the left hemisphere was stored at 280uC for biochemical analysis. The average survival times of the experimental groups were analyzed by one-way ANOVA and the Tukey-Kramer multiple comparison test.
Histopathological studies
The right hemisphere was fixed in 10% buffered formalin solution. Coronal slices of the brain were cut and immersed in 98% formic acid to reduce infectivity, and then embedded in paraffin wax. Sections with a thickness of 4 mm were cut and stained with hematoxylin and eosin (HE), or analyzed by immunohistochemistry. For the neuropathological analysis, the lesion profile was determined from the HE-stained sections by scoring the vacuolar changes in nine standard gray matter areas, as described previously [29] . For immunohistochemistry, PrP Sc was detected in brain sections by the hydrated autoclaving method using anti-PrP monoclonal antibody 31C6 against the epitope of amino acids 143-149 of the mouse prion protein [30] . Immunoreactions were developed using anti-mouse universal immunoperoxidase polymer (Nichirei Histofine Simple Stain MAX-PO (M), Nichirei, Tokyo, Japan) as the secondary antibody, and 3-39 diaminobenzedine tetrachloride as the chromogen.
Results
Cofactor activity of insect cell lysates became functional after proteinase K digestion and heat treatment As reported previously, proteinase K (PK)-resistant Bac-PrP (Bac-PrP res ) was generated by PMCA using Bac-PrP expressing insect cells and Prnp 0/0 mouse brain homogenate (Prnp 0/0 BH) (KO-PMCA; Figure 1A , lanes 1 and 2). Bac-PrP was partially purified by about 37-fold from the lysates of Bac-PrP-expressing cells using immobilized metal ion affinity chromatography (IMAC). The proportion of Bac-PrP in the IMAC-purified fraction was approximately 8.8% of the total protein ( Figure 1B Further, we examined insect cell lysates in terms of potential cofactor activity. HighFive TM (HF) cell lysate (10 ml of 2.5610 4 cells/ml in 16 PBS, 4 mM EDTA, 1% Triton X-100; NTHF) was
In Vitro PrPadded to the IMAC-purified Bac-PrP, and then amplified. As expected, no significant cofactor activity was detected in the cell lysate ( Figure 1A , lanes 9 and 10). It is noteworthy that a significant cofactor activity became obviously observed in the cell lysates after protease digestion and heat treatment (PKHF) ( Figure 1A , lanes 13 and 14). We designated this PMCA using PKHF and IMAC-purified Bac-PrP as PKHF-PMCA. Proteins in the HF cell lysate were digested with PK, and the samples were incubated at 100uC for 2.5 h to inactivate protease activity completely. Coomassie Brilliant Blue (CBB) staining of the gel loaded with PKHF indicated that almost all proteins in PKHF were digested with PK. However, several bands or smeared signals that might be peptide fragments or their aggregates were recognized by silver staining ( Figure 1C ). Although the heat treatment alone induced cofactor activity in the insect cell lysate ( Figure 1A , 100HF, lanes 11 and 12), the signal intensity of BacPrP res was significantly less than that of the amplification using protease-treated lysates. These results suggested that cofactors necessary for in vitro amplification of Bac-PrP res were also present in the insect cells, but unlike mammalian cofactors, protease digestion and/or heat-induced alteration were required for the functional expression of insect-derived cofactors.
Cofactor activity of insect and mammal cell lines for BacPrP res amplification
To investigate whether other insect or mammal cell lines also possess cofactor activity for Bac-PrP res amplification, we carried out PMCA using an insect cell line SF21 and a mouse neuroblastoma cell line N2a. Non-treated SF21 cell lysate did not induce Bac-PrP res amplification as observed in the HF cells (Figure 2A, lanes 11 and 12) . However, N2a cell lysate induced a low level of amplification of Bac-PrP res without PK and heat treatments ( Figure 2A, lanes 13 and 14) . PK and heat treatments of the SF21 cell lysate induced a significant cofactor activity for Bac-PrP res amplification; the cofactor activity of N2a cell lysate was also enhanced by these treatments (Figure 2A, lanes 3-8) . These results indicated that the expression of cofactor activity upon PK and heat treatments was not specific to the HF cell line, and these treatments were also effective for the insect and mammalian cell lines examined. In contrast to the insect cells, at least partial cofactor activity was recognized in the N2a cell lysate without PK and heat treatments.
Next, we examined the cofactor activity of PK-and heat-treated insect cell lysates using brain-derived PrP C as the substrate. Mammalian PrP C was purified from Tga20 mouse brain homogenates by IMAC ( Figure 2B right panel) . Amplification of Chandler-derived mammalian PrP res was observed using PK-and heat-treated HF, SF21 and N2a cell lysates ( Figure 2B , lanes 5-10), although the amplification activity was lower than Prnp 0/0 BH. These results showed that the PK-and heat-treated cell lysates can also enhance the amplification of mammalian PrP C to PrP res .
RNA and DNA stimulate the amplification of Bac-PrP res in PKHF-PMCA As demonstrated above, the cofactors for replication of BacPrP res are suggested to be non-proteinaceous biomolecules shared by both mammals and insects. Several reports have shown that RNA facilitated PrP Sc amplification in PMCA. Therefore, we investigated whether nucleic acids are involved in the process of replication of Bac-PrP res in PKHF-PMCA. Nucleic acids were degraded and decreased after PK and heat treatments, but fragments ranging from about 100 to 1000 bp were obviously detected in PKHF ( Figure S1A, lanes 1 and 2) . Nucleic acids remained in RNase-or DNase-treated PKHF, although they were degraded to undetectable levels in benzonase-treated PKHF ( Figure S1A, lanes 3-5) . The amplification efficiencies of BacPrP res in Chandler-seeded PKHF-PMCA were unaffected by RNase-or DNase-treatment ( Figure 3A, lanes 1-6) . However, benzonase treatment decreased the signal intensity of Bac-PrP derived total RNA, and PCR products. The addition of polyA recovered the amplification activities of benzonase-treated PKHF, equivalent to that of untreated PKHF ( Figure 3A, lanes 13-16) , and enabled serial amplification of Bac-PrP res ( Figure 3A , lanes13 and 14, R2 and R3). Total RNA from mouse brains also showed effective rescue capability ( Figure 3B, lanes 7 and 8) . The size of the polyA ranged from 200 bp to 6 kb, and the total RNA contained mainly 18S (1.8 kb) and 28S ribosomal RNA (4.8 kb) ( Figure S1B, lanes 1 and 2) . The addition of PCR products of 101-822 bp in length ( Figure S1B , lanes 3-6) also recovered the amplification activities of benzonase-treated PKHF ( Figure 3A , lanes 19 and 20; Figure 3B , lanes 9-16) Meanwhile, the addition of dNTP did not affect the amplification efficiency of Bac-PrP Sc ( Figure 3A, lanes 21 and 22) . In addition to the PCR products, circular plasmid DNA (approximately 9.6 kb) effectively recovered the amplification activity of benzonase-treated PKHF, but the larger genomic DNA failed to rescue amplification activity ( Figure 3C ). These results suggested that in addition to RNA, DNA fragments of appropriate sizes (101 to 9600 bp) also acted as cofactors for Bac-PrP res amplification, and their nucleotide sequences and structures (linear or circular) had no marked influence on cofactor activity.
Effect of lipids on amplification of Bac-PrP res
Although Bac-PrP res replication by PKHF-PMCA using Chandler PrP Sc seed was largely attributable to the cofactor activities of RNA and DNA with particular sizes, benzonase-treatment did not completely inhibit the cofactor activity of PKHF. This observation suggested that other factors were also involved in Bac-PrP res amplification in the PKHF-PMCA. Recently, it has been reported that synthetic phosphatidylglycerol and RNA or synthetic phosphatidylethanolamine (PE) alone facilitate the conversion of purified E. coli-derived recombinant PrP (E. coli-PrP) into PrP Sc [6, 31] . We therefore investigated the cofactor activity of lipids for the amplification of Bac-PrP res under the condition of PBS buffer containing TritonX-100 and EDTA. The signal intensity of PrP res did not differ very much before and after the amplification, indicating that total lipids extracted from mouse brains (Figure 4 , lanes [13] [14] [15] [16] [17] [18] [19] [20] and synthetic PE (Figure 4, lanes 23-30) induced no significant PrP res amplification with either strain in the presence or absence of nucleic acids such as polyA or DNA. These observations suggested that synthetic PE was not a functional cofactor for the amplification of Bac-PrP res in the present experimental condition. Moreover, the total lipids present in the mouse brains showed little effect on the amplification of BacPrP res . Another implication of the experimental results was that nucleic acids alone were not effective for Bac-PrP res amplification. These results suggested that other cooperative substances were necessary for the expression of the cofactor activity of nucleic acids.
Cofactor activities of PKHF and Prnp 0/0 BH for various prion strains
Our results revealed that nucleic acids contained in PKHF were essential cofactors for the amplification of Chandler Bac-PrP Sc . To determine whether nucleic acids are also effective for the amplification of Bac-PrP Sc of other prion strains, we used the PrP Sc from six mouse-adapted scrapie strains and one BSE strain (mBSE) as seeds for PMCA in the presence or absence of nucleic acids. All PrP Sc samples examined were amplified by one round of PKHF-PMCA in the presence of nucleic acids ( Figure 5A , top panel). Following the digestion of nucleic acids with benzonase, the cofactor activity of PKHF was reduced significantly in the amplification using Chandler, 79A, ME7, Obihiro, Tsukuba-2, and mBSE PrP Sc seeds ( Figure 5B) . A statistically significant improvement in amplification efficiency of Bac-PrP Sc was observed in these prion strains after the addition of synthetic polyA to benzonase-treated PKHF relative to the additive-free BH, PK-and heat-treated HF, SF21, N2a or Escherichia coli lysates. The PMCA products were digested with PK (50 mg/ml) at 37uC for 1 h, and analyzed by Western blotting. NA indicates the result of amplification without any additives (IMAC-purified Br-PrP C alone). Normal mouse BH (BH) was also used as a PrP C source for comparison of amplification. The amount of IMAC-purified Br-PrP C (approximately 750 ng/100 ml reaction solution) used as the PrP C source was almost equal to that of the PrP C contained in the 10% normal mouse BH (right panel). The western blot images are composite photos comprising band images from different gels. doi:10.1371/journal.pone.0082538.g002
In Vitro PrPcases. RNA-depleted plasmid DNA also showed an effect similar to polyA, and there were no significant differences between RNA and DNA in these strains. These results suggested that both RNA and DNA were involved in Bac-PrP Sc amplification for these prion strains. With regard to 22L, PrP Sc amplification efficiency was not significantly affected by benzonase treatment in the first round of IMAC-purified Bac-PrP was used as the PrP C source, and Chandler and ME7 PrP Sc (diluted 1:1000) was amplified in buffer solution (0.1% Tx100, 4 mM EDTA, 16 PBS) in the absence (NA) or presence of nucleic acids (polyA, 2 or 10 mg; purified 822-bp PCR product, 2 mg). PMCA was also performed in buffer solution containing brain-derived total lipids (equivalent to 2.5 mg of brains) or synthetic phosphatidylethanolamine (18:1, P1223, Sigma, 2.5 mM). Amplification using PKHF was performed for comparison. NA indicates no additives. Each sample was digested with PK (50 mg/ml) at 37uC for 1 h, and analyzed by Western blotting. Western blot analysis was also performed prior to amplification to determine the signal intensity of each PrP Sc seed (lanes [33] [34] [35] [36] . The western blot images are composite photos comprising band images from different gels but same membranes. doi:10.1371/journal.pone.0082538.g004
In Vitro PrPamplification ( Figure 5B) , and PrP Sc signal intensity remained to be low during four rounds of amplifications ( Figure S2 ). On the other hand, 22L PrP Sc signal intensity increased drastically after the third round of amplification using non-treated PKHF ( Figure  S2 and Figure 5B ). Therefore, it is highly possible that nucleic acids act as a cofactor for the amplification of 22L PrP Sc . Next, we compared the amplification efficiency of PrP Sc between PKHF-PMCA and KO-PMCA ( Figure 5B) . Although insect cells expressing Bac-PrP were used as the PrP C source for KO-PMCA, insect cell-derived cofactor activity was not involved in KO-PMCA because the insect cell-derived cofactors were not able to function without protease digestion and heat treatment. After one round of PKHF-PMCA, the signal intensities of BacPrP res in the ME7 and Obihiro strains were higher than those of KO-PMCA. In the case of the amplification of Chandler, 79A, 22L, and mBSE PrP Sc seeds, the amplification efficiencies of PKHF-PMCA were less than those of KO-PMCA. PKHF-PMCA and KO-PMCA had very low Bac-PrP res generation rates in the Tsukuba-2 strain after one round of amplification. However, the Bac-PrP res signal was easily detectable after five rounds of serial PKHF-PMCA in Tsukuba-2, and Bac-PrP res signals were maintained or enhanced during five rounds of PKHF-PMCA in the other strains (Figures S2 and 5B) . On the other hand, Bac-PrP res signals were undetectable after five rounds of serial KO-PMCA in the ME7, Obihiro, and Tsukuba-2 strains. These results showed that PKHF-PMCA was more effective than KO-PMCA for continuous generation and replication of Bac-PrP res in various prion strains suggesting that the cofactors involved in Bac-PrP Sc amplification were different between PK and heat-treated insect cell lysates and brain homogenates.
Detection sensitivity of PKHF-PMCA
We compared the amplification efficiency of PrP Sc by PMCA using three different combinations: insect cofactors and insect PrP substrate (PKHF-PMCA), mammalian cofactors and insect PrP substrate (KO-PMCA), and mammalian cofactors and mammalian PrP substrate (BH-PMCA, Figure 6 ). In the case of the amplification of mBSE PrP Sc , the PMCA was highly sensitive and exhibited similar detection sensitivities for the PrP Sc after four rounds of amplification: PrP res could be detected up to 10 210 dilution by PKHF-PMCA and BH-PMCA, and up to 10 29 dilution by KO-PMCA. However, the amplification efficiencies were considerably different in the case of ME7 PrP Sc . KO-PMCA was less useful for the sequential amplification of ME7 PrP Sc , as shown in Figure 5 . BH-PMCA was also insufficient to maintain ME7 PrP Sc sequential amplification [23] . On the other hand, PrP res could be amplified efficiently by serial PKHF-PMCA, and detected up to 10 29 dilution of ME7-infected BH after four rounds of amplification ( Figure S3 ). These results suggested that PKHF-PMCA using insect cofactors worked well for ultrasensitive detection of PrP Sc in these mouse-adapted prion strains, as compared to PMCA using mammalian cofactors.
Biological and biochemical properties of PKHF-PMCA products
To investigate the infectivity of the PKHF-PMCA product, the amplified products obtained after 10 (Chandler-seeded) or 13 (mBSE-seeded) rounds of serial PMCA, which did not contain seed PrP Sc were intracerebrally inoculated to C57BL/6J mice. The PMCA products were infectious, and the mice inoculated with the products obtained by serial amplification of Chandler and mBSE PrP Sc developed the disease after 16269 days (n = 8) and 193611 days (n = 7), respectively. Control mice administered nonseeded PMCA products survived more than 421 days (n = 6).
Further, we examined the neuropathological properties of the PKHF-PMCA products. The regional profiles of neuronal vacuolation scores in the brains of the mice inoculated with the PMCA-derived PrP Sc were very similar to those of the mice inoculated with the brain-derived PrP Sc in both Chandler and mBSE prion strains ( Figure 7A ). Immunohistochemical analysis of the hippocampus and the occipital cortex of the affected mice revealed strain-specific characteristics in the mice inoculated with the PKHF-PMCA-derived PrP Sc or the brain-derived PrP Sc . In the case of the Chandler strain, PrP Sc accumulated over the entire region of the brain sections with diffuse distribution and synaptic- BH (KO-PMCA). The PMCA products were digested with PK (50 mg/ml) at 37uC for 1 h and analyzed by Western blotting. The results of the first and fifth rounds of amplification are presented; profiles from the second to fourth rounds of amplification of each strain are provided in Figure S2 . NS indicates the no-seed control. The Western blot images in panel A are composite photos comprising band images from different gels. (B) IMAC-purified Bac-PrP was used as the PrP C source and PrP Sc (diluted 1:1000) from six scrapie and one BSE mouse-adapted prion strains were amplified in the presence of non-treated PKHF or benzonase-treated PKHF. For PMCA using benzonase-treated PKHF, amplification was performed in the absence (white bars) or presence of synthetic polyA (2 mg; black bars) or plasmid DNA (2 mg; hatched bars). The conversion efficiencies for each sample were expressed as a percentage change (mean 6 standard error (SE) relative to the control value (control = 100)). The conversion value of PMCA using non-treated PKHF was used as a control. The results were analyzed by one-way ANOVA and the Tukey-Kramer multiple comparison test. PMCA was performed between three to six times. doi:10.1371/journal.pone.0082538.g005
In Vitro PrPlike immunostaining, and the accumulation patterns of PrP Sc were very similar between mice inoculated with the PMCA-derived PrP Sc and the brain-derived Chandler PrP Sc . In contrast, in the mBSE strain, dense granular PrP Sc deposition in the hippocampus and peculiar lamellar accumulation of PrP Sc in the occipital cortex were observed in mice inoculated with the PMCA-derived PrP Sc and brain-derived mBSE PrP Sc . Moderate degenerated neurons in the CA1 region of the hippocampus were found commonly in these mice.
In addition, the glycosylation patterns and molecular weights of PrP Sc accumulated in the brains of the mice inoculated with PKHF-PMCA-derived PrP Sc were indistinguishable from those of the mice inoculated with brain-derived PrP Sc of the Chandler and mBSE strains ( Figure 7C ). These results suggested that the PKHF-PMCA using only insect cell-derived substances was capable of amplifying infectious PrP Sc with strain-specific pathogenic properties.
Discussion
In the current study, we demonstrated that insect cells also contained the cofactors required for in vitro replication of GPIanchored Bac-PrP Sc that preserved the strain characteristics of the PrP Sc seed. Mammalian cofactors contaminating the PrP Sc seeds appeared to not participate in the replication because purified PrP Sc (SAF) was also amplified effectively by PKHF-PMCA ( Figure S4 ). Unlike brain-derived mammalian cofactors, PK digestion and/or heat treatment were necessary for the cofactor activities in insect cell lysates. We demonstrated that both RNA and DNA were important for PrP Sc amplification via reconstitution experiments following benzonase treatment, although it has been shown that DNA could be substituted for RNA in RML PrP Sc amplification under RNA-depleted PMCA conditions [32] . Furthermore, we found that the nucleic acid dependency of in vitro In Vitro PrPamplification of Bac-PrP Sc was not necessarily the same among prion strains.
There are several possible explanations for the lack of cofactor activity in the untreated insect-cell lysates. For example, most nonproteinaceous cofactors, such as nucleic acids, might exist in conjugated or aggregated states with cellular proteins in the insectcell lysate; therefore, the active sites necessary for the expression of cofactor activities might be masked by such forms. Protease digestion or heat treatment of cellular proteins might allow the cofactors to become functional by dissociating the aggregates. Alternatively, the non-proteinaceous cofactors might be functional even in untreated cell lysates, but some kind of inhibitory factors present in the insect cells might interfere with the conversion of PrP C to PrP Sc . The latter possibility is strongly supported by the results that amplification of Bac-PrP Sc was efficiently inhibited by adding untreated insect cell lysates into the PKHF-PMCA reaction solution ( Figure S5 ). Such inhibitory factors could be proteins because their inhibitory activities were lost by protease digestion or heat treatment. Lactoferrin, a multifunctional glycoprotein belonging to the transferrin family, has been reported to inhibit PrP Sc replication in murine cell lines and PrP Sc amplification by PMCA [33] . Although insect cells produce transferrins that have various biological functions, including roles in iron transport, antioxidative stress, and anti-infective activity [34] , there was no evidence that lactoferrin-like molecules were present in the cell lysates. Nonetheless, our results ( Figure S5 ) strongly suggested that certain inhibitory factors were present in the insect cell lysate. Such inhibitory factors might also be contained in a certain type of mammalian cell lines and therefore, PK/heat-treatment might be necessary to express full cofactor activity in N2a cells (Figure 2A) .
The functional roles of nucleic acids as cofactors are not clear. Nucleic acids contained in PKHF were fragmented to sizes of 100-1000 bp, likely due to digestion with endogenous nucleases and denaturation by heat ( Figure S1A ). The size of the DNA significantly influenced cofactor activities, and DNA fragments or plasmids of 101-9600 bp functioned well as cofactors. Therefore, it was possible that the fragmentation of genomic DNA was involved in the expression of cofactor activity in insect cells. Fragmented and deproteinized nucleic acids could acquire the ability to interact with PrP to enhance the structural conversion of PrP C to PrP Sc . Alternatively, the binding of PrP to nucleic acids of appropriate sizes could prevent random PrP aggregate formation, or such nucleic acids might serve as a scaffold for the orderly accumulation of PrP Sc . In PKHF-PMCA, nucleic acid depletion had little effect on the first round of PrP Sc amplification in the 22L strain ( Figure 5A ). This observation suggested that cofactors, other than nucleic acids, were involved in PKHF-PMCA. Synthetic phospholipids, such as phosphatidylglycerol (POPG) or phosphatidylethanolamine (PE), are known to act as cofactors for the generation and amplification of GPI-anchorless E. coli-PrP [6, 31] . However, in the presence of brain-derived total lipids or PE, and even with the combination of these lipids and nucleic acids, Bac-PrP res was not generated by PMCA using Chandler and ME7 PrP Sc (Figure 4 ). In addition to nucleic acids and phospholipids, polysaccharides, including glycosaminoglycans (GAG), sulfated dextran, and heparin, are known to stimulate PrP res conversion [7, 35] or PrP Sc amplification [16, 36] . Furthermore, low-molecular-weight molecules, such as Cu 2+ ions [37, 38] and NADPH [11] , have been suggested to be involved in the in vitro conversion of brain-derived PrP C or E. coliPrP. These PK-resistant and heat-stable molecules mentioned above may have been present in the lysate of insect cells and some factors in them could have either acted as a cofactor alone or participated cooperatively in the functional expression of the cofactor activity of nucleic acids. Further studies are needed to fully identify and understand the cofactors involved in the amplification of GPI-anchored Bac-PrP Sc , as well as to examine the cofactor preference of each prion strain, which may hold the key to the prion diversity problem. The reconstitution experiment using GPI-anchored Bac-PrP performed in the current study may be applied to the characterization of mammalian cofactors present in BH.
In conclusion, we revealed in this study that the essential cofactor molecules needed for the high-fidelity replication of mammalian PrP
Sc were also present in insect cells, where protease digestion and/or heat treatment were required for the functional expression of cofactor activity. We showed that DNA of appropriate sizes (101 to 9600 bp) represented some of the nonproteinaceous cofactor molecules in insect cells, but our results suggested that other cellular factors were necessary for amplification. Finally, PMCA using only insect cell-derived substances (iPMCA) resulted in successful amplification of various prion strains, showing low background (nonspecific) signals and high sensitivity. Sc were amplified by PKHF-PMCA using infected-BH and the SAFs as seeds. In the case of Chandler, similar amounts of BacPrP res were produced after amplification using infected BH (contained 4.8 ng of PrP res ) or the SAF (10 ng). In contrast, mBSE-infected BH (contained 9.6 ng of PrP res ) yielded a higher efficiency of amplification compared to mBSE SAF (10 ng). (C) The PKHF-PMCA products using SAF seeds were infectious, and all mice (n = 8) inoculated with the products developed prion disease (Chandler, 17468 days; mBSE, 20863 days). Western blot analysis indicated that the band patterns were very similar between the PrP Sc in brains inoculated with SAF-based PMCA products and those inoculated with infected BH-based PMCA products.
Supporting Information
(TIF) Figure S5 The inhibitory effect of non-treated insect HighFive TM cell lysates (NTHF) on Bac-PrP Sc amplification. Ten microliters of non-treated HighFive TM cell lysates (2.5610 4 /ml in 1% Triton X100, 4 mM EDTA, 16 PBS; NTHF) was added into PKHF-PMCA reaction solution, and PMCA was conducted. Bac-PrP Sc amplification was efficiently inhibited by addition of NTHF. (TIF)
